Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 30, Issue 6, 2008, Pages 469-472

  Zhou, Song wen ^a   Ren, Sheng xiang ^a   Yan, Ling hua ^a   Zhang, Ling ^a   Zhou, Cai cun ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; QUINAZOLINE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE COURSE; DRUG ANTAGONISM; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; QUALITY OF LIFE; REMISSION; SALVAGE THERAPY; TREATMENT FAILURE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; QUALITY OF LIFE; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 67650841110     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)